DNA Methylation Market is forecasted to grow at high rate due to an increase in government spending on research & development facilities, a rise in disposable income, and increase in awareness regarding protein-based therapy. The Global DNA Methylation Market was valued at USD 1.5 Bn in 2020 and is expected to reach USD 4.5 Bn by 2027, with a growing CAGR of 17.0% during the forecast period
DNA methylation is process which involves transfer of methyl group to the C-5 position of DNA strand which helps in sequencing the DNA. Moreover, DNA methylation regulates the gene expression by recruiting proteins involved in particular gene expression. This led to change in pattern of DNA such as de novo DNA methylation and demethylation. DNA methylation helps to operate both physical and mental process of the body.
The driving factors influencing the growth of global DNA methylation market include rise in adoption of genomics procedures among geriatric population in the treatment of chronic diseases, increase in healthcare spending and growing demand for gene-based therapy. Moreover, decline cost of treatment and rise in output of sequencing, increase in product launch and approvals fuels the growth of global DNA methylation market. Emergence of innovative techniques in gene sequencing will provide a lubricative growth of global DNA methylation industry. Further, growth in early-stage biomarker in cancer profiling is a major key driver in the growth of global DNA methylation market.
This industry is broadly segmented into product, technology, application, and region. Based on product, consumables dominated the growth of DNA methylation market in 2020 due to rise in its diagnostics usage. Based on technology, polymerase chain reaction segment accounted for the highest market share in 2020 due to increase in its application in diagnostics and DNA sequencing process. Based on application, oncology segment accounted for the highest market share owing to increase in various types of cancer such as breast cancer, blood cancer, lung cancer. Geographically, North America accounted for the highest market share in 2020 due to presence of majority of players in this region.
Global DNA Methylation Market by Region Outlook (Revenue, USD Million, 2021-2027)
Based on region, North America held maximum market share in 2020 about 75% due to increase in prevalence of cancer in this region and demand for gene-based therapy. Moreover, increase in number of hospitals in this region, rise in disposable income and government spending on healthcare and research facilities fuels the growth of DNA methylation market in this region. Technological advances, demand for precision medicines further boost the growth of global DNA methylation market.
On the contrary, Asia-Pacific anticipate highest market growth during forecast period due to increase in diversification in healthcare market, growing adoption of protein-based therapies, and growing R&D facilities boost the growth of global DNA methylation industry in this region.
The Global DNA Methylation Market Segmentation:
Global DNA Methylation Market by Product Type Outlook (Revenue, USD Million, 2021-2027)
Global DNA Methylation Market by Technology Type Outlook (Revenue, USD Million, 2021-2027)
Global DNA Methylation Market by Application Type Outlook (Revenue, USD Million, 2021-2027)
Company Profiles and Competitive Intelligence
The key players operating in the DNA methylation market are: